Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
IOL Chemicals & Pharmaceuticals Ltd has informed BSE regarding the details of 29th Voting results at the Annual General Meeting (AGM) of the Company held on September 28, 2016, under Regulation 44(3) of SEBI (LODR) Regulations, 2015 along with Scrutinizer's Report. Outcome of AGM
IOL Chemicals & Pharmaceuticals Ltd has submitted to BSE Proceedings of 29th Annual General Meeting (AGM) of the Company held on September 28, 2016. Updates Corporate Presentation
IOL Chemicals & Pharmaceuticals Ltd has informed BSE regarding "Updates Corporate Presentation". Newspaper advertisement for Notice of the 29th Annual General Meeting containing the details and manner of electronic voting
IOL Chemicals & Pharmaceuticals Ltd has submitted to BSE a copy of Newspaper advertisement for Notice of the 29th Annual General Meeting containng the details and mannder of electronic voting. Fixes Book Closure for AGM (Cut-off date for e-voting)
IOL Chemicals & Pharmaceuticals Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed on September 21, 2016 for the purpose of 29th Annual General Meeting (AGM) of the Company to be held on September 28, 2016. Standalone Financial Results, Limited Review Report, Results Press Release for June 30, 2016
IOL Chemicals & Pharmaceuticals Ltd has informed BSE about : 1. Standalone Financial Results for the period ended June 30, 20162. Standalone Limited Review for the period ended June 30, 20163. Result Press Release for the period ended June 30, 2016 Board Meeting Intimation for Results & Closure of Trading Window
IOL Chemicals & Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors of the company will to be held on August 08, 2016, inter-alia, to consider and approve the un-audited financial results of the Company for the quarter ended June 30, 2016.Further, in terms of provisions of the Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders, the "Trading Window" of the Company shall remain closed from... Better intraocular lens
The US Food and Drug Administration has approved the first intraocular lens (IOL) that provides cataract patients with an extended depth-of-focus to help improve the sharpness of vision at near, inte... Shareholding for the Period Ended June 30, 2016
IOL Chemicals & Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2016. For more details, kindly Click here Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016
IOL Chemicals & Pharmaceuticals Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.